References
1. Ponikowski P, Voors AA, Anker SD, Bueno H, Rutten FH, van der Meer P,
et al. Group ESCSD. 2016 ESC Guidelines for the diagnosis and treatment
of acute and chronic heart failure: The Task Force for the diagnosis and
treatment of acute and chronic heart failure of the European Society of
Cardiology (ESC) developed with the special contribution of the Heart
Failure Association (HFA) of the ESC. European heart
journal,2016;37:2129-2200.
2. McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, et
al. angiotensin-neprilysin inhibition versus enalapril in heart failure.
N Engl J Med. 2014 Sep 11;371(11):993-1004
3. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Colvin MM, et
al. 2016 ACC/AHA/HFSA focused update on new pharmacological therapy for
heart failure: an update of the 2013 ACCF/AHA guideline for the
management of heart failure: a report of the American College of
Cardiology/ American Heart Association Task Force on clinical practice
guidelines and the Heart Failure Society of America. J Am Coll Cardiol
2016; 68: 1476–1488.
4.
Duk-Hyun
Kang, Sung-Ji Park, Sung-Hee Shin, Geu-Ru Hong, Sahmin Lee, Min-Seok
Kim, et al. Circulation. 2019;139:1354–1365. DOI:
10.1161/CIRCULATIONAHA.118.037077
5. Velazquez EJ, Morrow DA, DeVore AD, Duffy CI, Ambrosy AP, McCague K,
et al. Angiotensin-Neprilysin Inhibition in Acute Decompensated Heart
Failure. N Engl J Med. 2019 Feb 7;380(6):539-548
6. Pandey A., Clarus S., Verma S. The impact of ARNI therapy on LV
systolic function as measured by 2-D echocardiography: a 1 year case
series, Canadian J of Card,
Volume 33,
issue 10, supplement , S161-S162
7. Bayard G, Da Costa A, Pierrard R, Roméyer-Bouchard C, Guichard JB,
Isaaz K. Impact of sacubitril/valsartan on echo parameters in heart
failure patients with reduced ejection fraction a prospective
evaluation. Int J Cardiol Heart Vasc. 2019;25:100418. Published 2019 Sep
3. doi:10.1016/j.ijcha.2019.100418
8.
Liu
LW,
Wu
PC,
Chiu
MY,
Tu
PF,
Fang
CC, Sacubitril/Valsartan Improves Left Ventricular Ejection Fraction
and Reverses Cardiac Remodeling in Taiwanese Patients with Heart Failure
and Reduced Ejection Fraction.
Acta Cardiol Sin.
2020 Mar;36(2):125-132